ask="N/A"
ask_size="N/A"
average_daily_volume="24402"
bid="3.15"
bid_size="100"
book_value="2.04"
change="-0.24"
change_from_200_day_moving_average="-1.33"
change_from_50_day_moving_average="-0.73"
change_from_52_week_high="-3.69"
change_From_52_week_low="0.98"
change_in_percent="-5.06%"
close="4.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.73"
ebitda="-18.35M"
eps_estimate_current_year="-1.92"
eps_estimate_next_quarter="-0.40"
eps_estimate_next_year="-1.91"
ex_dividend_date="N/A"
float_shares="2933000"
high="4.70"
high_52_weeks="8.19"
last_trade_date="2/14/2017"
last_trade_price="4.50"
last_trade_size="16578"
last_trade_time="4:00pm"
low="4.50"
low_52_weeks="3.52"
market_capitalization="28.10M"
moving_average_200_day="5.83"
moving_average_50_day="5.23"
name="Aldeyra Therapeutics
Inc."
notes="N/A"
one_year_target_price="20.00"
open="4.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.75%"
percent_change_from_50_day_moving_average="-14.03%"
percent_change_from_52_week_high="-45.05%"
percent_change_from_52_week_low="+27.84%"
previous_close="4.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.32"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="6245000"
short_ratio="2.18"
stock_exchange="NCM"
symbol="ALDX"
volume="723586"
weeks_range_52="3.52 - 8.19"
